George Azrak

Asterand, Inc. is engaged in providing all the information and materials that are needed to conduct research on common disease targets, such as cancer, heart disease and brain disorders. The company is a privately held company founded in 2000 to address the urgent need of genomics and proteomics researchers for high quality biological information and materials. The customers of the company include researchers working at the world's foremost and oldest pharmaceutical, biotech, genomic and proteonic companies.